PMC - CEPI's Response to COVID-19
paperCredibility Rating
High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: PubMed Central
This resource covers pandemic preparedness policy and institutional coordination, not AI safety. It is tangentially relevant only as a reference model for rapid-response infrastructure planning analogous to proactive AI governance frameworks.
Metadata
Summary
This Lancet Infectious Diseases article covers CEPI's $3.5 billion 5-year strategic plan launched in 2021 to reduce pandemic and epidemic risks, building on COVID-19 vaccine development successes. CEPI prioritizes next-generation vaccines, rapid-response platform technologies for unknown 'Disease X' pathogens, and vaccines against known threats like filoviruses and Lassa fever. The initiative represents a major institutional commitment to pandemic preparedness infrastructure.
Key Points
- •CEPI launched a $3.5 billion, 5-year strategic plan in March 2021 focused on pandemic and epidemic preparedness beyond COVID-19.
- •Key priorities include rapid-response platform technologies capable of producing vaccines against unknown 'Disease X' pathogens within 100 days.
- •CEPI funded early development of mRNA and adenovirus-vectored COVID-19 vaccines, demonstrating the value of advance investment in platform technologies.
- •The plan targets vaccines for known epidemic threats including filoviruses (Ebola/Marburg) and Lassa fever alongside broader preparedness.
- •Improved manufacturing, equitable global delivery, and next-generation vaccine formulations are central to CEPI's forward-looking strategy.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Organization | 53.0 |
Cached Content Preview
[Skip to main content](https://pmc.ncbi.nlm.nih.gov/articles/PMC8063073/#main-content)

**Official websites use .gov**
A
**.gov** website belongs to an official
government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** (
Lock
Locked padlock icon
) or **https://** means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
[Home](https://pmc.ncbi.nlm.nih.gov/ "Home")

Search PMC Full-Text Archive
Search in PMC
- [Journal List](https://pmc.ncbi.nlm.nih.gov/journals/)
- [User Guide](https://pmc.ncbi.nlm.nih.gov/about/userguide/)
- 
- [](https://doi.org/10.1016/S1473-3099(21)00216-4) View on publisher site
- [](https://pmc.ncbi.nlm.nih.gov/articles/PMC8063073/pdf/main.pdf) Download PDF
- Add to Collections
- Cite
- Permalink
## PERMALINK
Copy

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
[PMC Discla
... (truncated, 12 KB total)463164d2b60f980e | Stable ID: YzUwMzEzNG